Aripiprazole Open-Label, Safety and Tolerability Study

Completed · Phase 3

Conditions studied: Schizophrenia, Bipolar Disorder

In brief

The purpose of this study is to test the long-term safety and tolerability of aripiprazole in adolescent patients with schizophrenia, and child and adolescent patients with bipolar I disorder, manic or mixed episode.

Key facts

Study ID

NCT00102518

Run by

Otsuka Pharmaceutical Development & Commercialization, Inc.

People needed

325

Starts

2004-09-01

Expected to finish

2007-02-01

Last updated by the study team

2012-08-31

Who can join

Age: 10 and older, up to 17. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adolescent patients with schizophrenia, or child and adolescent patients with bipolar I disorder, manic or mixed episode

You may not qualify if…

• Patients with a co-morbid serious, uncontrolled systemic illness
• Patients with a significant risk of committing suicide

Where it is running

• Local Institution — Birmingham, Alabama, United States
• Local Institution — Little Rock, Arkansas, United States
• Local Institution — Costa Mesa, California, United States
• Local Institution — Fresno, California, United States
• Local Institution — Orange, California, United States
• Local Institution — Riverside, California, United States
• Local Institution — Rosemead, California, United States
• Local Institution — Sacramento, California, United States
• Local Institution — Temecula, California, United States
• Local Institution — Washington D.C., District of Columbia, United States
• Local Institution — Altamonte Springs, Florida, United States
• Local Institution — Fort Lauderdale, Florida, United States
• Local Institution — Hialeah, Florida, United States
• Local Institution — Jacksonville, Florida, United States
• Local Institution — Miami, Florida, United States
• Local Institution — Orange City, Florida, United States
• Local Institution — Tampa, Florida, United States
• Local Institution — Atlanta, Georgia, United States
• Local Institution — Honolulu, Hawaii, United States
• Local Institution — Chicago, Illinois, United States
• Local Institution — Kansas City, Kansas, United States
• Local Institution — Lexington, Kentucky, United States
• Local Institution — Louisville, Kentucky, United States
• Local Institution — Lake Charles, Louisiana, United States
• Local Institution — Metairie, Louisiana, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.